cirm.ca.gov12d
CIRM invests $10 million to build California Cell and Gene Therapy Manufacturing Network
The statewide network is designed to overcome manufacturing bottlenecks that have delayed or stalled development and approval of regenerative medicines. “These awards are a critical first step in ...
cirm.ca.gov6d
Retinal progenitor cells for treatment of retinitis pigmentosa
Retinitis pigmentosa is a blinding eye disease that affects approximately 150,000 individuals in the US and 1.5 million people around the world. It is caused by the destruction of light-sensing… ...
cirm.ca.gov8d
Stem Cell Agency Invests $32 Million Toward Therapies For Spinal Cord Injury and HIV/AIDS
San Diego, CA – A promising treatment for patients with spinal cord injuries and a therapy aimed at helping HIV patients create an AIDS-resistant blood system were approved today by the state’s stem ...
cirm.ca.gov10d
Year 4/NCE
Most heart conditions leading to sudden death or impaired heart pumping functions in the young people ( 35 years old) are the results of genetic mutations inherited from parents. It is very difficult ...
cirm.ca.gov16d
Our Programs
CIRM’s core programs focus on critical areas that drive the development and commercialization of regenerative medicine treatments. Spanning education, research, and funding opportunities, these ...
cirm.ca.gov1mon
CIRM Awards Nearly $100 Million to Boost Discovery, Translational, and Clinical Disease Research
South San Francisco, CA, January 30, 2025 – The California Institute for Regenerative Medicine (CIRM), one of the world’s largest institutions dedicated to regenerative medicine, has awarded nearly ...
cirm.ca.gov3d
Erradicación terapéutica de células madre cancerosas con UC-961 (Cirmtuzumab)
El cáncer es una de las principales causas de muerte en California. Las investigaciones han demostrado que muchos cánceres pueden propagarse por todo el cuerpo y resistir las terapias actuales contra ...
cirm.ca.gov1mon
Our Leadership
Jonathan Thomas, PhD, JD, is President and CEO of the California Institute for Regenerative Medicine (CIRM). Thomas was previously the Chair of the CIRM governing Board from June 2011 to March 2023.
cirm.ca.gov2y
CIRM Clinical Trials
Through its strategic funding of clinical trials, CIRM helps advance innovative stem cell and gene therapy discoveries toward future treatments for patients. CIRM funds clinical trials across a broad ...
cirm.ca.gov2mon
帕金森病 (PD) 细胞疗法的开发候选者
帕金森病 (PD) 是一种毁灭性的疾病，它会夺走充满活力、富有成效的成年人的活力，并耗尽我们的医疗费用。 它也是研究其他神经退行性疾病的绝佳模型。 我们发现，人类神经干细胞 (hNSC) 可能 ...
cirm.ca.gov1mon
Public Meetings
Get the latest CIRM news, information on upcoming meetings, and funding opportunities delivered to your inbox.
cirm.ca.gov2y
Frequently Asked Questions (FAQs)
Welcome to the frequently asked questions (FAQs) page of the California Institute for Regenerative Medicine (CIRM). Here, you’ll find answers to the most common questions you may have on CIRM. CIRM, ...